Search

Your search keyword '"Pelletier, C."' showing total 37 results

Search Constraints

Start Over You searched for: Author "Pelletier, C." Remove constraint Author: "Pelletier, C." Search Limiters Full Text Remove constraint Search Limiters: Full Text
37 results on '"Pelletier, C."'

Search Results

1. Cost of ligno-cellulosic biomass production for bioenergy: A review in 45 countries.

2. A 16-week randomized controlled trial evaluating the physical activity guidelines for adults with spinal cord injury.

3. Exercise equipment preferences among adults with spinal cord injury.

4. Direct referral and physical activity counselling upon discharge from spinal cord injury rehabilitation.

5. Muscle fatigue characteristics in paralyzed muscle after spinal cord injury.

6. The length–tension relationship of human dorsiflexor and plantarflexor muscles after spinal cord injury.

7. Six methodological steps to build medical data warehouses for research

8. Thermogenesis and weight loss in obese individuals: a primary association with organochlorine pollution.

9. PSS23 DISEASE BURDEN IN PATIENTS WITH MILD PSORIASIS: GROUP CONCEPT MAPPING.

11. C-03 Embedded Validity Indicators in Conners' Continuous Performance Test, Second Edition (CPT-II) Discriminate Valid from Invalid Profiles More Accurately during the Repeat Administration in a Psychiatric Sample.

17. The effects of exercise training on physical capacity, strength, body composition and functional performance among adults with spinal cord injury: a systematic review.

18. The impact on patient flow after the integration of nurse practitioners and physician assistants in 6 Ontario emergency departments.

19. PND120 TREATMENT PATTERNS AMONG PATIENTS WITH MULTIPLE SCLEROSIS INITIATING SECOND-LINE DISEASE-MODIFYING THERAPY.

20. PSS14 REAL-WORLD COSTS IN BIOLOGIC-NAIVE PSORIASIS PATIENTS INITIATING APREMILAST OR BIOLOGICS IN A US HEALTHCARE CLAIMS DATABASE.

21. PMS55 TREATMENT PATTERNS AMONG MS PATIENTS NEWLY INITIATING DISEASE-MODIFYING THERAPY.

24. Nucleophosmin protein expression level, but not threonine 198 phosphorylation, is essential in growth and proliferation.

27. PND19 PRODUCTIVITY LOSS AMONG CAREGIVERS OF PATIENTS WITH MS.

29. PCN151 IMPACT OF ADVERSE EVENTS (AES) ON HEALTHCARE RESOURCE UTILIZATION (HRU) AND TOTAL COSTS OF CARE (TCOC) AMONG PATIENTS WITH LARGE B-CELL LYMPHOMA (LBCL).

30. PSS15 REAL-WORLD COSTS IN BIOLOGIC NAIVE PSORIATIC ARTHRITIS PATIENTS INITIATING APREMILAST OR BIOLOGICS IN A US HEALTHCARE CLAIMS DATABASE.

31. ND3 SHORT- AND LONG-TERM DISABILITY BURDEN AMONG EMPLOYED PATIENTS RECEIVING DISEASE-MODIFYING TREATMENT FOR MULTIPLE SCLEROSIS.

32. Mood and Anxiety Disorders in Canada, 2016.

Catalog

Books, media, physical & digital resources